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Abstract: Hypoxia-inducible factor 1 (HIF-1) is a transcription
complex that plays a pivotal role in cellular adaptation to hypoxic
conditions. The role of this factor in inflammatory reactions associ-
ated with infections and allergies has recently become evident. In
this review we summarize our current knowledge concerning the
accumulation and role of HIF-1 in Toll-like receptor-mediated and
allergic inflammation. The differential molecular mechanisms used
to stabilize this protein in various settings and its ability to support
both proinflammatory and angiogenic responses suggest important
functional roles in both innate immune responses and allergies.
Importantly, the HIF-1 transcription complex is activated in human
basophils during IgE-mediated inflammatory responses. It is in-
volved in VEGF expression and subsequent promotion of angiogen-
esis and in controlling energy metabolism.
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INTRODUCTION
Normal and pathologic functioning of the human immunesystem is always associated with the inflammatory pro-
cess. During inflammation immune cells concentrate in tissue
sites affected by injury with a pathogen or allergen.1,2 Such
processes give rise to an increased blood supply to the injured
area followed by an increase in capillary permeability and
leukocyte migration into the tissue.1,2 These events therefore
lead to decreased oxygen availability in these inflamed tissues
where the effector cells are exposed to a hypoxic environ-
ment. In addition, during inflammatory reactions the intracel-
lular oxygen consumption is increased and this is associated
with an increase in the activity of ATP-degrading kinase
cascades. Therefore, hypoxia becomes the normal physiolog-
ical environment of inflammatory processes,3,4 which in-
cludes several stages5:
1. Interaction of proinflammatory ligands with plasma mem-
brane-associated or endosomal receptors such as Toll-like
receptors (TLRs) that cause intracellular inflammatory
stress.
2. Adaptation of the inflammatory effector cells to stress
associated with low oxygen availability.
3. Ligand-induced inflammatory receptor-mediated expres-
sion of proinflammatory cytokines, which promote fur-
ther stages of host immune defense or allergic reactions.
The key stage of the inflammatory process is adaptation of the
effector cells to inflammatory stress. Nonadapted cells will be
quickly eliminated by the activation of cell death mecha-
nisms.5 Therefore, upon interaction with proinflammatory
ligands, the effector cells use adaptation mechanisms that
allow them to survive and act under hypoxic conditions. This
report summarizes our current knowledge about the role of
hypoxic signaling pathways driven by the hypoxia-inducible
factor 1 (HIF-1) transcription complex3 in adapting effector
cells to inflammatory stresses caused by infectious and aller-
gic inflammation.
SIGNALING RECEPTORS REGULATING
INFECTIOUS AND ALLERGIC INFLAMMATION
TLRs are key pattern-recognition receptors (PRRs) that
allow immune cells to specifically detect pathogen-associated
molecular patterns and induce inflammatory responses to
them.6–8 Because of the ability of TLRs to specifically
recognize pathogen-associated ligands, they lie at the core of
host resistance to infectious disease. Examples of TLR li-
gands include lipopolysaccharides (LPS; recognized by
TLR4), lipopeptides and peptidoglycan (PGN, recognized by
cooperation of TLR2 with TLR1 or TLR6), flagellin (specific
TLR5 ligand), viral single- or double-stranded RNA (de-
tected by TLR7/TLR8 and TLR3, respectively), and bacterial
or viral DNA containing CpG motifs (TLR9 ligands).1,7–9
TLR activation results in the recruitment of signaling inter-
mediates, which include myeloid differentiation factor-88
(MyD88), Toll-interleukin (IL)-1 receptor (TIR)-associated
protein (TIRAP, also known as MAL), Toll receptor-associ-
ated activator of interferon (TRIF), Toll receptor-associated
molecule (TRAM), IL-1 receptor-associated kinases (IRAK),
and tumor necrosis factor (TNF) receptor-associated factor 6
(TRAF6).6,8 TLRs are expressed in many leukocytes and
tissue cell types, while the key effectors of inflammation/
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innate immunity are myeloid macrophages, neutrophils, and
dendritic cells.6,8,10
However, pathogens are not the only cause of inflam-
matory reactions. A number of human disorders such as
allergic asthma, atopic dermatitis, allergic rhinitis, heyfever,
and many others are associated with nonpathogenic inflam-
matory reactions.2 This type of inflammatory response is
known as allergic inflammation, the key effectors of which
are basophils and mast cells.2,11 Both types of cells are
granulated and play different roles in adaptive and innate
immune responses including promotion and regulation. Mast
cells were found to express different angiogenic factors
during inflammation and as such stimulate the process of
angiogenesis.2,12,13 Currently, it was reported that basophils
play a critical role in inflammatory angiogenesis, mostly via
the expression of several isoforms of vascular endothelium
growth factor (VEGF) and its receptors.2,14–18 Basophils and
mast cells are 2 distinct hematopoietic lineages that play
complementary or overlapping roles during acute and chronic
immunoglobulin E (IgE)-associated allergic inflammatory
reactions.2,14
Both basophils and mast cells express the tetrameric
form of the plasma membrane-associated high-affinity recep-
tor FcRI. This receptor recognizes IgE, inducing down-
stream signaling events leading to the allergic inflammatory
response. Both basophils and mast cells are crucial effectors
of T-helper 2 (TH2) cell-dependent, IgE-associated hypersen-
sitivity reactions. Activated human basophils and mast cells
express and release TH2 cytokines such as IL-13 and IL-4 that
polarize immune responses, and produce biochemical medi-
ators such as histamine and lipid metabolites (eg, leukotri-
enes), which are crucial for both regulation of immune
reactions and chemotaxis.2,11,13,14,16,19
It is important to mention that basophils also express
TLRs, especially TLR2, 4, 9 and 10 and respond to some of
the TLR ligands.20 Therefore, it is likely that basophils recruit
stress adaptation signaling pathways similar to those ob-
served in the innate immune cells. As such, similar molecular
mechanisms might participate in both infectious and allergic
inflammation. Intriguingly, recent evidence clearly demon-
strated that in both kinds of inflammation, the innate immune
cells and basophils/mast cells recruit HIF-1 transcription
complex during their adaptation to inflammatory stress.
HIF-1 TRANSCRIPTION COMPLEX
HIF-1 is a transcription complex consisting of 2 sub-
units, inducible HIF-1 and constitutive HIF-1 this subunit
as also acts as aryl hydrocarbon receptor nuclear translocator
or ARNT).21Under normal oxygen conditions, HIF-1 pro-
tein undergoes regulated ubiquitination that causes its protea-
somal degradation. HIF-1 interacts with the von Hippel-
Lindau protein (pVHL), interacting with its oxygen-dependent
degradation domain and targeting the protein for proteasomal
degradation. VHL is also associated with elongins B and C,
cullin-2, and possibly other factors that belong to E3 ubiq-
uitin ligase functioning as a multiprotein complex. Interaction
between pVHL with HIF-1 protein is regulated via hydroxy-
lation of 402/564 proline residues. This process is catalyzed
by HIF-1 prolyl hydroxylase (PHDs) enzymes.21 HIF-1
PHDs recruit molecular oxygen, iron (II), 2-oxoglutarate
(2-OG), and ascorbic acid during their catalytic action. Under
hypoxic conditions prolyl hydroxylation of the HIF-1 sub-
unit is down-regulated, and therefore the protein undergoes
rapid stabilization.21
There is now increasing evidence regarding the accu-
mulation of HIF-1 protein followed by HIF-1 transactiva-
tion in different types of innate immune cells in response to
TLR-ligand interactions.4,22–25 Intriguingly, both membrane-
associated and endosomal TLRs were found to trigger acti-
vation of the HIF-1 transcription complex.5 Furthermore,
FcRI was also reported to use HIF-1 in its downstream
signaling.18 However, differential biochemical mechanisms
are used in these cases to induce HIF-1 accumulation and
HIF-1 transactivation.
MOLECULAR MECHANISMS OF HIF-1
ACTIVATION IN HUMAN IMMUNE
CELLS DURING INFECTIOUS AND
ALLERGIC INFLAMMATION
The molecular mechanisms leading to the HIF-1 ac-
cumulation have been studied mostly for TLR4 (cell mem-
brane associated) and TLRs 7 and 8 (endosomal receptors). In
the case of TLR4 a redox-dependent mechanism is one of the
contributors to the accumulation process.26–28 In this case
direct phosphorylation of the protein is also required for
successful accumulation/transactivation of the HIF-1 pro-
tein.26 Furthermore, an increase in HIF-1 mRNA was also
detected.22,26 After interaction with LPS, the intracellular TIR
domain of the TLR4 binds myeloid differentiation factor 88
(MyD88), which recruits Bruton disease (Btk). Before the
interaction with MyD88, Btk undergoes phosphorylation by
Src and most likely other tyrosine kinases. Upon interaction
with MyD88, Btk phosphorylates TIRAP, which interacts
with MyD88 with high affinity.29,30 Being a part of the
multiprotein complex described above, Btk phosphorylates
PI-3-specific phospholipase C (PLC-1), which then gains
catalytic activity26,29,30 and indirectly activates protein kinase
C (PKC)  and  isoforms.26,31 PKC/ could then phos-
phorylate the protein p47phox.32,33 Phosphorylated p47phox
induces assembly of the cell membrane-associated six-protein
complex that gains NADPH oxidase activity and therefore
produces reactive oxygen species (ROS),27,28,32,33 contribut-
ing to HIF-1 accumulation.
However, in this case the contribution from MAP
kinase pathways is also essential. MAP kinase pathways
driven by apoptosis signal-regulating kinase 1 (ASK1) are
recruited. ASK1 and its downstream p38 MAP kinase and
ERK (its activation does not depend on the ASK1) were
found to contribute to the LPS-induced, TLR4-dependent
accumulation of the HIF-1 protein.26,34 LPS-dependent
TLR4 signaling triggers cross-talk of ASK1 and HIF-1
protein.26 ASK1 is selectively required for the activation of
p38 MAP kinase during TLR4 downstream signaling.35,36 p38
contributes to HIF-1 protein stabilization by its direct phos-
phorylation.26,37 Earlier reports have demonstrated that ERK is
also critical for TLR4-mediated HIF-1 accumulation.34
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Endosomal TLRs 7 and 8 trigger differential mecha-
nisms to activate HIF-1 protein. In this case, a redox-
dependent mechanism similar to the one observed for TLR4
takes place. However, in this case IRAKs 1 and 4 were also
found to indirectly contribute to the activation of NADPH
oxidase and therefore to influence ROS generation.25 Earlier
studies reported the direct contribution of IRAK1/4 to the
phosphorylation of p47phox and causing the assembly of the
NADPH oxidase complex during TLR signaling.37 Reactive
nitrogen species (RNS) are also involved in TLR7/8-induced
activation of HIF-1 protein.25 ASK1, PI3K, ERK, and p38
do not influence HIF-1 accumulation and HIF-1 transacti-
vation in this case.25 Although HIF-1 protein is one of the
potential targets for posttranslational modification via its
direct S-nitrosation.21,38 This type of protein modification is
not a major contributor to the TLR7/8-mediated HIF-1
accumulation.39 ROS in the case of TLR4, ROS/RNS in the
case of the TLR7/8, down-regulate HIF-1 prolyl hydroxy-
lation leading to the accumulation of the protein, because of
an inability to interact with the VHL protein.39 NADPH
oxidase-derived ROS were reported to negatively influence
HIF-1 PHDs in other cases such as intermittent hypoxia.40
Another report demonstrated a decrease in the expression of
these enzymes in the cells exposed to LPS.24 Our studies have
demonstrated a decrease but not an attenuation of HIF-1
prolyl hydroxylation in human myeloid macrophages in re-
sponse to LPS exposure.39
The HIF-1 protein is also known to be stabilized in
basophils during allergic inflammation.18,40 This HIF-1 ac-
cumulation has been found to occur in an IgE-dependent
manner.18 However, in this case, both ERK and p38 MAP
kinase contribute to HIF-1 protein accumulation. Interest-
ingly, ASK1, ROS, and PI3K did not influence anti-IgE-
induced HIF-1 accumulation in primary human basophils.18
The results showing changes in accumulation of HIF-1
protein upon pretreatment of basophils with pharmacological
inhibitors of p38, ERK, and PI3 kinase before exposure to
anti-IgE were inconsistent with those obtained with histamine
release associated with degranulation. These experiments
suggest that PI3 kinase is the major contributor to IgE-
induced histamine release, which is also supported by the p38
MAP kinase. HIF-1 accumulation (not expression) was not
dependent on PI3 kinase; however, it was affected in the case
of attenuated ERK/p38 activities.18 The mechanisms of the
IgE-induced HIF-1 accumulation are summarized in the
Figure 1.
DIFFERENTIAL FUNCTIONAL ROLE OF THE HIF-
1 TRANSCRIPTION COMPLEX IN REGULATION
OF HUMAN INFLAMMATORY REACTIONS
Functionally, the HIF-1 transcription complex is one of
the major contributors to the inflammatory process. As the
transcription factor triggered by hypoxia or stress, HIF-1
controls the adaptation of effector immune cells to inflam-
matory stress, protecting them against quick apoptosis and
allowing them to generate an inflammatory response (eg,
production of proinflammatory cytokines). In the cases of
both infectious and allergic inflammation, HIF-1 supports
energy metabolism, especially glycolysis, and, as such, pre-
vents ATP depletion. In addition, HIF-1 contributes to the
tracking of the ASK1 activity (in the cases when ASK1
activation takes place) preventing over-activation of the en-
zyme that would lead to quick and often irreversible activa-
tion of apoptotic signaling pathways inducing programmed
cell death.18,25,41,42 The HIF-1 transcription complex controls
the expression of the protein phosphatase PP5 known to
specifically down-regulate ASK1 activity.43 By supporting
cell survival, HIF-1 supports the production of proinflamma-
tory cytokines (IL-6 and TNF-) in innate immune cells
during TLR-mediated inflammatory processes.25,42 Impor-
tantly, recent evidence demonstrated the role of HIF-1 in
expression of the cell membrane-associated TLR4.44
Expression of the proallergic cytokine IL-4 is also
supported by HIF-1 in a similar way.18 In human basophils,
HIF-1 facilitates cellular adaptation to IgE-mediated stress
and promotion of cytokine expression. However, these pro-
cesses are differentially regulated compared with degranula-
tion and histamine release.18
FIGURE 1. Biochemical mechanisms of HIF-1 protein ac-
cumulation and its differential functional role in IgE-medi-
ated responses of basophils. Mechanisms leading to the
accumulation and activation of HIF-1 protein during IgE-
induced proallergic responses are presented. Differential
functional roles of HIF-1 in cellular adaptation to inflamma-
tory stress is summarized.
WAO Journal • October 2010 Differential Role of HIF-1
© 2010 World Allergy Organization 247
In both kinds of inflammation the HIF-1 transcription
complex directly controls expression of VEGF, thus regulat-
ing angiogenic processes.3,18,25 Adhesion of immune cells
and neovasculature also depends on HIF-1, which regulates
the expression of CD182 adhesion integrins. Adhesion of
immune cells is vital for the proper innate immune response
and its correct linking to adaptive immune reactions. It is also
crucial for the development of allergic reactions.4 The func-
tional role of the HIF-1 transcription complex in the allergic
inflammatory responses is outlined in Figure 1.
Recent clinical studies have demonstrated that the
HIF-1 transcription complex and VEGF play an important
role in inflammation and hypervascularization observed in
cases of bronchial asthma.45,46 This suggests that further in
vivo studies are required to investigate the concept described
in this paper.
All these important functions are not yet a definitive list
in terms of fully describing the contribution of the HIF-1
transcription complex in inflammatory processes and several
aspects of HIF-1 activation during infections remain unclear.
In the case of allergic inflammation, further complex studies
have to be performed to clarify HIF-1 activation mechanisms
in human basophils and mast cells and its functional role in
pathologic cell reactions associated with allergic responses
and disorders.
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